verapamil has been researched along with amyloid beta-peptides in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crawford, F; Fang, C; Mullan, M; Suo, Z | 2 |
Beyreuther, K; Masters, CL; Sáez-Valero, J; Sberna, G; Small, DH | 1 |
Hong, S; Nazer, B; Selkoe, DJ | 1 |
4 other study(ies) available for verapamil and amyloid beta-peptides
Article | Year |
---|---|
Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity.
Topics: Amyloid beta-Peptides; Antipsychotic Agents; Aorta; Apoptosis; Calcium; Calcium Channel Blockers; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Endothelium, Vascular; Free Radicals; Humans; Necrosis; Peptide Fragments; Pimozide; Superoxide Dismutase; Superoxides; Time Factors; Verapamil | 1997 |
The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholinesterase; Amyloid beta-Peptides; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Embryonal; Diltiazem; Gene Expression Regulation, Enzymologic; Kinetics; Marine Toxins; Nifedipine; Oxocins; Peptide Fragments; Tumor Cells, Cultured; Verapamil | 1997 |
Characteristics of the in vitro vasoactivity of beta-amyloid peptides.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aorta; Calcimycin; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cerebral Amyloid Angiopathy; Drug Synergism; Endothelin-1; Endothelium, Vascular; Ionophores; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Verapamil | 1998 |
LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Biotinylation; Blood-Brain Barrier; Calcium Channel Blockers; Cell Line, Transformed; Dogs; Endocytosis; Epithelial Cells; Hormone Antagonists; Iodine Isotopes; Low Density Lipoprotein Receptor-Related Protein-1; Mifepristone; Models, Biological; Peptide Fragments; Time Factors; Transfection; Verapamil | 2008 |